Pseudomonas infections persisting after CFTR modulators are widespread throughout the lungs and drive lung inflammation

Abstract excerpt

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators improve the physiological defect causing cystic fibrosis, but the lungs of most people remain infected and inflamed. A leading hypothesis implicates damaged segments as the cause of persistent infection and predicts that mildly diseased segments within an individual's lungs will clear after treatment, whereas severely diseased segments will...

Topics

Join the communities discussing this publication.

• Asthma and respiratory diseases
• Cystic Fibrosis Research Advances
• Inhalation and Respiratory Drug Delivery